Aardvark Therapeutics, Inc.
AARD
$7.95
-$0.74-8.52%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -4.62% | 0.00% | 764.42% | -- | -- |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -61.80% | 0.00% | 76.59% | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -30.96% | 0.00% | 55.12% | -- | -- |
| Total Current Assets | -4.97% | 0.00% | 739.01% | -- | -- |
|
|
|||||
| Total Current Assets | -4.97% | 0.00% | 739.01% | -- | -- |
| Net Property, Plant & Equipment | 700.95% | 0.00% | -32.26% | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 114.81% | 0.00% | 730.77% | -- | -- |
| Total Assets | -3.97% | 0.00% | 727.66% | -- | -- |
|
|
|||||
| Total Accounts Payable | -45.59% | 0.00% | 18.26% | -- | -- |
| Total Accrued Expenses | 21.94% | 0.00% | 466.38% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 199.07% | 0.00% | -3.57% | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | -1.92% | 0.00% | 92.69% | -- | -- |
|
|
|||||
| Total Current Liabilities | -1.92% | 0.00% | 92.69% | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 18.55% | 0.00% | 85.70% | -- | -- |
|
|
|||||
| Common Stock & APIC | 10.26% | 0.00% | 4.19% | -- | -- |
| Retained Earnings | -9.22% | 0.00% | -20.21% | -- | -- |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -9.14% | 0.00% | -21.56% | -- | -- |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -0.07% | 0.00% | 188.91% | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -0.07% | 0.00% | 188.91% | -- | -- |
|
|
|||||
| Total Common Equity | -9.14% | 0.00% | -21.56% | -- | -- |
| Total Preferred Equity | -0.07% | 0.00% | 188.91% | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.68% | 0.00% | 828.80% | -- | -- |
|
|
|||||
